Background: Cyclic ADP-ribose (cADPR) has been shown to act as a potent cytosolic mediator in a variety of tissues, regulating the release of Ca 2+ from intracellular stores by a mechanism that involves ryanodine receptors. There is controversy over the effects of cADPR in cardiac muscle, although one possibility is that endogenous cADPR increases the Ca 2+ sensitivity of Ca 2+ -induced Ca 2+ release (CICR) from the sarcoplasmic reticulum. We investigated this possibility using 8-amino-cADPR, which has been found to antagonize the Ca 2+ -releasing effects of cADPR on sea urchin egg microsomes and in mammalian cells (Purkinje neurons, Jurkat T cells, smooth muscle and PC12 cells).
Background
Changes in cytosolic Ca 2+ provide an important signalling mechanism for the regulation of a great diversity of cell functions; it is believed that the release of Ca 2+ from intracellular stores plays a major role in generating these signals. In recent years, evidence has accumulated supporting the hypothesis that the endogenous molecule, cyclic ADP-ribose (cADPR), modulates Ca 2+ release from intracellular stores in a variety of cell types [1] [2] [3] [4] [5] . The pharmacology of cADPR-induced Ca 2+ release is consistent with a mechanism of action that involves the ryanodine receptor Ca 2+ -release channel. As it is well known that the ryanodine receptor plays a crucial role in Ca 2+ -induced Ca 2+ release (CICR) from the sarcoplasmic reticulum in cardiac muscle [6] , we investigated the possible role of cADPR in the regulation of the cardiac ryanodine receptor during excitation-contraction coupling in the heart. Although such a regulatory role for cADPR has not yet been established in the heart, the enzymes for synthesis and degradation of cADPR are known to be present in cardiac muscle [7] , and endogenous concentrations of approximately 200 nM have been reported [8] . It has been shown recently that cADPR promotes the release of Ca 2+ from isolated cardiac sarcoplasmic reticulum [9] , but other studies have failed to demonstrate such effects [10] or have found actions which appear to be antagonized by ATP at concentrations expected to be present in the cytoplasm of intact cells [11] .
One experimental tool for the study of cADPR mechanisms is its 8-amino derivative; this has been shown to be a competitive antagonist of cADPR both in sea urchin egg preparations [12] and in mammalian cells (Purkinje neurons [13] , Jurkat T cells [14] , intestinal smooth muscle cells [15] and PC12 cells [16] ). To further investigate the possibility that endogenous cADPR may modulate excitation-contraction coupling in cardiac muscle, we have studied the effects of 8-amino-cADPR on Ca 2+ transients and contractions of guinea-pig ventricular cells. Preliminary observations have been presented to The Physiological Society [17] .
Results
Single cardiac myocytes were isolated from guinea-pig ventricle and impaled with double-barrelled 'theta-glass' sharp microelectrodes, allowing one barrel to be used for electrical recording, and the other for cytosolic application of drugs (after obtaining a series of measurements in the absence of drug). In the first set of experiments, Ca 2+ -dependent inward currents were used to report cytosolic Ca 2+ , allowing Ca 2+ transients to be monitored. Cell shortening was measured from the video image of cells using an edge-detection system. (Details of these techniques are given in the Materials and methods section). Figure  1a shows the effects of cytosolic injection of 8-aminocADPR (at a pipette concentration of 20 M) on Ca 2+ transients in 15 cells stimulated to fire action potentials at 1 Hertz. 8-amino-cADPR caused a substantial reduction of the Ca 2+ transient within 3 minutes of application, with a slightly greater degree of suppression evident at 8 minutes: after 3 minutes, the peak (at 50 milliseconds) was reduced to 68 ± 3 % that of control (p < 0.05), and after 8 minutes the peak magnitude was 59 ± 3 % of the pre-drug value. Quantitatively similar effects of 8-aminocADPR on the magnitude of cell contraction were observed in 13 of these 15 cells (Fig. 1b; contraction measurements could not be made in two cells because of poor image quality): the peak magnitude of cell shortening relative to control was 70 ± 4 % at 3 minutes and 62 ± 5% at 8 minutes (p < 0.05). The reductions in Ca 2+ transients and contractions were comparable, although slightly less than those seen with ryanodine to suppress CICR under similar conditions (see below). The residual contraction may be largely supported by Ca 2+ influx through the sarcolemma (see later). The effects of 8-amino-cADPR on Ca 2+ transients and contraction were not accompanied by any significant changes in action potential duration (see Fig. 1 , legend).
Heat treatment (above 70°C for 2 hours) of 8-aminocADPR abolished its ability to antagonise the Ca 2+ releasing actions of cADPR in sea urchin egg preparations (data not shown). Application of heat-inactivated 8-aminocADPR was therefore used in control experiments in cardiac myocytes to test for possible effects of the injection method or time. Figure 2 shows the effects of application of the heat-treated solution in amounts equivalent to 20 M 8-amino-cADPR (mean of seven cells). The 
Control
cytosolic application of heated 8-amino-cADPR was without significant effect (p > 0.05) on both the Ca 2+ transient and cell contraction: at 3 and 8 minutes, the peak of the steady state Ca 2+ transient was 102 ± 2 % and 102 ± 2 % of that before injection, and cell shortening was 99 ± 6 % and 99 ± 8 % of the pre-injection value. Action potential durations at 90 % repolarization were also unchanged in these seven cells (255 ± 20 milliseconds before, and 257 ± 16 milliseconds after cytosolic application of heat-treated 8-amino-cADPR). In another series of control experiments, cells were injected with HEPES buffer which did not contain 8-amino-cADPR; again there was no significant effect on Ca 2+ transients (11 cells) or on contraction (9 cells) 8 minutes after cytosolic application (the peak of the Ca 2+ transient was 103 ± 10% of that before injection of HEPES, and peak cell shortening was 99 ± 2 % that of the control value).
The suppression by 8-amino-cADPR of the peak magnitude of the Ca 2+ transient was found to exhibit a concentration-dependence over the range 200 nM to 20 M (pipette concentration), as shown in Figure 3 . A similar concentration-dependence was observed for the decrease in cell contraction (Fig. 3) . Note that the concentrations in the cytosol are expected to be much lower than those in the pipette, as access to the cytosol from these sharp electrodes is expected to be restricted (see Materials and methods). Some variability in the ratio of pipette-tocytosol concentrations is also likely between experiments as, for example, the precise dimensions of the microelectrode tip may influence access of the drug from the pipette to the cytosol. Nevertheless, it is clear that concentration dependence was observed, despite these limitations.
In a further set of experiments, the Ca 2+ sensitive dye fura-2 was used to monitor Ca 2+ transients in cells injected with 8-amino-cADPR (see Materials and methods for details). To investigate whether the observed reduction of Ca 2+ transients and contractions by 8-amino-cADPR might be due to an influence on Ca 2+ entry through L-type Ca 2+ channels, L-type Ca 2+ currents were compared before and after injection of 20 M 8-amino-cADPR. Figure 5a shows representative examples of Ca 2+ currents recorded before and after injection of 20 M 8-amino-cADPR (these currents were evoked by 200 millisecond step depolarizations from -40 to 0 mV). The current-voltage relations for peak Ca 2+ current, averaged from six cells, are plotted in Figure 5b . 8-amino-cADPR was without significant effect on the current-voltage relation, demonstrating that its suppression of Ca 2+ transients and contractions was not attributable to an action on Ca 2+ entry from the extracellular space through sarcolemmal Ca 2+ channels.
To test whether the suppressive actions of 8-aminocADPR might be due to an action at the level of Ca 2+ release from intracellular stores, the effects of 20 M 8-amino-cADPR were studied in cells exposed to 2 M ryanodine to inhibit the functioning of the sarcoplasmic reticulum [18] [19] [20] . As shown in Figure 6 , ryanodine markedly suppressed Ca 2+ transients and associated contractions in cells stimulated to fire action potentials, and increased the time to peak of the former. Subsequent injection of 8-amino-cADPR in the continued presence of ryanodine was without significant further effect on either the time to peak or the magnitude of the Ca 2+ transient and cell contraction (Fig. 6 ). These observations are therefore consistent with an inhibitory action of 8-aminocADPR on the Ca 2+ transient (in the absence of ryanodine) as a consequence of reduced Ca 2+ release from the sarcoplasmic reticulum; this inhibitory action is prevented by ryanodine, which suppresses release from Ca 2+ stores. As the majority of the calcium-activated current is carried by Na + :Ca 2+ exchange, the lack of effect of 8-amino-cADPR on calcium-activated currents in the presence of ryanodine would exclude any direct effects of 8-amino-cADPR on the Na + :Ca 2+ exchanger.
To determine whether the inhibitory action of 8-aminocADPR on the Ca 2+ transient and cell contraction might involve a reduction in the quantity of Ca 2+ available for 992 Current Biology 1996, Vol 6 No 8
Figure 3
Concentration-dependent suppression of peak Ca 2+ -activated tail currents and peak cell contraction by 8-amino-cADPR. Ca 2+ -activated currents were measured for action potentials abbreviated at 50 msec release from intracellular stores, contractions in response to rapid applications of caffeine were monitored [21] . Cytosolic application of 8-amino-cADPR (20 M in the pipette) did not reduce caffeine-induced contractions, even though, in the same cells, it did suppress Ca 2+ transients and cell contractions accompanying action potentials (as in Fig. 1 ). Indeed, there was a small, but statistically significant (p < 0.05), increase in the magnitude of the contractile response to caffeine (from 13.2 ± 1.4 % to 15.1 ± 1.3 %, expressed as a percentage of resting length; n = 7). This increase may be associated with a slight enhancement of the amount of Ca 2+ available for release from the sarcoplasmic reticulum when the release process is inhibited by 8-amino-cADPR. Thus, the inhibitory effects of 8-amino-cADPR on Ca 2+ transients and cell contraction cannot be accounted for by a reduction in the degree of loading of intracellular stores (as assessed using this method).
Discussion
The observations presented above demonstrate that 8-amino-cADPR can suppress Ca 2+ transients, without reducing sarcolemmal Ca 2+ currents and without depleting intracellular Ca 2+ stores. The ability of ryanodine to abolish these effects is consistent with an action of the compound at the level of the sarcoplasmic reticulum. It is possible that 8-amino-cADPR could act to inhibit Ca 2+ -induced Ca 2+ release by a mechanism which does not depend on the action of cADPR, for example at sites on the ryanodine receptor normally bound by other nucleotides. However, in view of the evidence that 8-amino-cADPR antagonizes cADPR-induced but not caffeine-induced Ca 2+ release, and also competitively inhibits [ 32 P]-cADPR binding to sea urchin microsomes [12] , it is more likely that 8-amino-cADPR acts as a selective inhibitor at the cADPR-binding site without blocking ryanodine receptor activation by pharmacological agents such as caffeine.
Further support for this interpretation is provided by experiments showing an antagonism by 8-amino-cADPR of cADPR action in mammalian cells, including neurons [13] , T-lymphocytes [14] , intestinal smooth muscle cells [15] and PC12 cells [16] . In addition, 8-amino-cADPR did not reduce Ca 2+ release from the sarcoplasmic reticulum by caffeine in the experiments reported here. The most probable explanation for the observed effects of 8-aminocADPR in cardiac ventricular muscle, therefore, is an inhibition of the action of endogenous cADPR. These data provide the first direct evidence that endogenous cADPR plays an important role in regulating Ca 2+ release from the sarcoplasmic reticulum in intact myocytes, perhaps by modulating the sensitivity to Ca 2+ of the release channel, and hence may exert a strong influence on the force of contraction of cardiac ventricular cells.
As mentioned above, the enzymes for synthesis and degradation of cADPR have been shown to be present in cardiac muscle [7, 22] , and it has been estimated that cADPR is present in cardiac cells at a concentration of 200 nM [12] . However, the mechanisms regulating cADPR levels in cardiac cells have not yet been elucidated. In the sea urchin egg, there is evidence that nitric oxide, acting through a rise in cytosolic cGMP, may stimulate the production of cADPR [4] . In pancreatic ␤ cells, glucose-induced increases in cytosolic cADPR may play a
Research Paper cADPR and cardiac excitation-contraction Rakovic et al. 993 Control role in stimulus-secretion coupling [23, 24] . Another possible regulatory mechanism has been identified in mammalian intestinal longitudinal smooth muscle, where cholecystokinin-8 has been reported to enhance cADPR synthesis [15] . Possible roles of such regulatory factors in cardiac muscle remain for future study. A summary scheme to represent possible regulation of CICR by cADPR in cardiac muscle is shown in Figure 7 .
Release of Ca 2+ from the sarcoplasmic reticulum plays an important role not only during normal cardiac muscle contraction but also during abnormal conditions that lead to Ca 2+ overload and oscillations of cell Ca 2+ and membrane potential. These oscillations are thought to arise from cyclic release from, and uptake into, the sarcoplasmic reticulum stores, and are believed to underlie a variety of disturbances of the rhythm of the heart [25] . It is as yet unknown whether these oscillations are influenced by cytosolic levels of cADPR. Preliminary experiments reported by us to the joint meeting of Japanese and British Physiological Societies support this possibility, as 8-amino-cADPR (20 M in the pipette) was able to suppress oscillations provoked by exposure of guinea-pig ventricular myocytes to high concentrations of isoproterenol or ouabain [26] .
If, as suggested, Ca 2+ transients and therefore contractions are indeed influenced by endogenous levels of cADPR, the intriguing possibility is raised that novel inotropic agents might be developed to act at the cADPR receptor in the sarcoplasmic reticulum. In addition, if cADPR were to influence the Ca 2+ oscillations mentioned above, novel analogues of 8-amino-cADPR and cADPR may prove to be useful as potential antiarhythmic drugs, and establishment of the cADPR signalling pathway will provide yet more drug targets.
Conclusions
8-amino-cADPR applied to the cytosol of intact myocytes isolated from guinea-pig ventricle suppresses Ca 2+ transients and cell contractions, by reducing release of Ca 2+ from the sarcoplasmic reticulum. A direct effect Ryanodine itself caused a marked reduction in the Ca 2+ transient at all times (peak being reduced to 45 ± 3 % of control, p < 0.05), and increased the time to peak from 48 ± 3 msec to 118 ± 10 msec. Subsequent injection of 8-amino-cADPR (in the continued presence of ryanodine) was without significant further effect (peak magnitude 42 ± 5 % of the control value; time to peak 124 ± 10 msec). Each point is the mean of 5 cells; error bars represent standard errors of the mean. (b) In the same 5 cells, ryanodine caused a large reduction in the magnitude of cell contraction (to 21 ± 4% of control) with no significant effect on the time to peak (137 ± 3 msec before and 140 ± 5 msec after ryanodine). Subsequent cytosolic application of 8-amino-cADPR was without significant effect at both 3 min and 8 min (amplitude 19 ± 5 % of control, and time to peak 153 ± 11 msec). 
Materials and methods

Cell isolation and superfusion
Guinea-pigs were killed by cervical dislocation following stunning; the heart was excised, perfused with solution containing collagenase, and myocytes were isolated by methods described previously [27, 28] . Cells were superfused with a balanced salt solution (36°C, pH 7. 
Electrical recording and drug application
Microelectrodes were pulled from theta glass tubing, with one barrel containing electrolyte (4 M KMeSO 4 and 10 mM KCl) for recording, and the other barrel used for application of drugs [29, 30] . The drug application barrel was initially empty, and records could be taken from the myocyte with the electrode in place in the cell; drug-containing solution was then added to the top of the application barrel and travelled rapidly to the tip by capillary action. The drug entered the cell by diffusion. The times of exposure to drugs are quoted from the time of application of drug-containing solution to the application barrel. All drugs applied intracellularly were dissolved in 20 mM HEPES buffer, pH 7.3.
The recording barrel of the microelectrode was attached to an Axoclamp 2A recording system. Current clamp recording was used for action potentials (2 msec stimuli at 1 Hz), while 'switched' voltageclamping was used for calcium currents (cells were clamped at a holding potential of -40 mV to inactivate sodium current, and calcium currents were evoked by application of 200 msec step depolarizations to a range of potentials from -30 to +40 mV, at a frequency of 0.3 Hz).
Measurement of cell contraction
Cell contraction was monitored from the video image of cells viewed microscopically using an edge detection system (Brian Reece Scientific, Abingon, UK); time resolution was 20 msec per point, and length resolution across the screen was 1 in 1024 pixels.
Measurement of cytosolic Ca 2+ transients
Two methods were used for measurement of cytosolic calcium transients. In the first, Ca 2+ -activated inward currents (predominantly Na + :Ca 2+ exchange current perhaps with calcium-activated cation channel current) were recorded by interrupting action potentials with a voltage-clamp to -70 mV at various times after the upstroke; the currents recorded under these conditions (after rapid decay of capacity current and de-activating calcium currents) reflect calcium beneath the membrane and are abolished by the calcium chelator BAPTA [30] . Care was taken to ensure a steady state loading of stores by allowing at least four full action potentials before interruption. In the second set of experiments, cytosolic Ca 2+ was measured with the fluorescent indicator fura 2: excitation was via a quartz fibre optic at 340 ± 5 nm and 380 ± 5 nm, and collection was at 500 ± 20 nm [31] . Cells for fluorescence measurement had been loaded with 5 M fura-2-AM for 20 min.
In the steady state (before and after addition of a drug), fluorescence signals were very consistent in response to successive stimuli, and switching of wavelength was therefore carried out between action potentials. Eight responses were averaged at each wavelength (the sequence being four responses at 340 nm, eight at 380 nm and four at 340 nm). When compared in the same cells, the fluorescence method gave good agreement with that using Ca 2+ -activated currents, although the calcium transients were appreciably slowed by the fura-2 loading, most likely a result of the calcium buffering actions of fura-2 [31] .
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Figure 7
Hypothetical scheme for a role of cADPR in cardiac ventricular myocyte excitation-contraction coupling. The majority of calcium which activates the contractile apparatus is released from the sarcoplasmic reticulum in response to a small influx of trigger calcium through L-type calcium channels in the sarcolemma. This phenomenon, termed Ca 2+ -induced Ca 2+ release (CICR), is mediated via ryanodine receptors (RyRs). cADPR may sensitize RyRs to Ca 2+ and therefore enhance CICR and cardiac contractility. This influence of cADPR may be either direct, or involve putative cADPR-binding proteins (cADPR-BPs); a requirement for calmodulin (CaM) has also been proposed. cADPR is synthesized from ␤-NAD + by ADP-ribosyl cyclases (C; yellow). These enzymes are often bifunctional, also possessing the ability to hydrolyze cADPR to the inactive metabolite ADP-ribose (H, hydrolase; yellow). Phosphorylation of these enzymes may be an important way of regulating cADPR synthesis. 
Rapid application of caffeine
In some experiments, cell contraction in response to rapid and transient application of 50 mM caffeine was used as a measure of the loading of intracellular calcium stores. The rapid application of a high dose of caffeine is thought to result in the opening of ryanodine receptors in the sarcoplasmic reticulum, and hence the release of calcium from intracellular stores which in turn leads to cell shortening [21] . Rapid application of caffeine was achieved by pressure ejection (for 1-2 sec) of 50 mM caffeine from a micropipette positioned close to the cell under study.
Drugs
Ryanodine was obtained from Calbiochem, caffeine from Sigma. 8-amino-cADPR was synthesized by methods described previously [32] using several modifications of the method of Walseth and Lee [12] . 8-amino-cADPR was initially synthesized by coupling 8-amino-AMP (prepared by reduction of 8-azido-AMP with dithiothreitol) with nicotinamide mononucleotide in 75 % aqueous pyridine using dicyclohexylcarbodiimide. The product was purified by ion-exchange chromatography (as below) and was used for the next stage as its triethylammonium salt. Incubation with crude Aplysia ADP-ribosyl cyclase was monitored by HPLC and when cyclization was judged to be complete the 8-aminocADPR was purified by ion-exchange chromatography on Sepharose Q Fast Flow using a gradient of triethylammonium bicarbonate; the 8-amino-cADPR was used as its triethylammonium salt. After quantification by UV spectroscopy, the compound was thoroughly characterized by spectroscopic techniques and its purity assessed by HPLC.
